Study to Prevent Acute Kidney Injury After Cardiac Surgery Involving Cardiopulmonary Bypass

PHASE2UnknownINTERVENTIONAL
Enrollment

275

Participants

Timeline

Start Date

February 24, 2017

Primary Completion Date

August 31, 2021

Study Completion Date

August 31, 2021

Conditions
Acute Kidney Injury
Interventions
DRUG

ANG-3777

6 mg/mL BB3, IV, 4 days in a row, first dose must be within 4 hours after surgery, the next three doses will be approx. 24 hours after the last dose

DRUG

Placebo

Normal saline

Trial Locations (40)

10032

Columbia University Medical Center, New York

20814

Suburban Hospital, Bethesda

21201

University of Maryland Medical Center, Baltimore

22903

University of Virginia Health System, Charlottesville

27157

Wake Forest University School of Medicine, Winston-Salem

27710

Duke University, Durham

32207

Fleming Island Center for Clinical Research, Fleming Island

River City Clinical Research, Jacksonville

32610

UF Health at Unviersity of Florida, Gainesville

43210

Ohio State Wexner Medical Center, Columbus

44111

Cleveland Clinic Fairview, Cleveland

45220

TriHealth, Cincinnati

46804

Indiana Ohio Heart, Fort Wayne

49770

MidMichigan Medical Center Midland, Midland

Cardiac & Vascular Research Center of Northern Michigan, Petoskey

68506

Bryan Heart, Lincoln

75226

Baylor Jack and Jane Hamilton Heart and Vascular center- Soltero Cardiovascular Research Center, Dallas

75390

University of Texas Southwestern Medical Center, Dallas

90033

University of Southern California, Los Angeles

90048

Cedars-Sinai Medical Center, Los Angeles

92123

California Institute of Renal Reseach, San Diego

94304

Stanford University Medical Center, Palo Alto

06520

Yale University School of Medicine, New Haven

18618-686

Faculdade de Medicina da UNESP Campus de Botucatu, Botucatu

90040-371

Instituto de Cardiologia do Rio Grande do Sul / Fundação Universitária de Cardiologia (IC - FUC), Porto Alegre

14048-900

Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo (HCFMRP), Ribeirão Preto

15090-000

Fundação Faculdade Regional de Medicina de São José do Rio Preto, São José do Rio Preto

05403-000

Instituto do Coração do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (InCor - HCFMUSP), São Paulo

E2L 4L2

St. John Regional Hospital, Saint John

N6A 5A5

London Health Sciences Center, London

M5B 1W8

Saint Michael's Hospital, Toronto

H2W 1T8

CHUM - Hôtel Dieu, Montreal

H4A 3J1

MUHC - Royal Victoria Hospital, Montreal

G1V 4G5

Institut Universitaire de Cardiologie et de Pneumologie de Québec, Québec

0112

Israeli-Georgian Medical Research Clinic Helsicore, Tbilisi

0114

New Hospitals LTD, Tbilisi

0159

Bokhua Memorial Cardiovascular Center, Tbilisi

0167

Jerarsi JSC, Tbilisi

0186

Tbilisi Heart Center, Tbilisi

0519

Acad. G. Chapidze Emergency Cardiology Center, Tbilisi

All Listed Sponsors
collaborator

Everest Clinical Research

UNKNOWN

collaborator

CTI Clinical Trial and Consulting Services

OTHER

collaborator

Clinical Accelerator

INDUSTRY

lead

Angion Biomedica Corp

INDUSTRY